Glutamine prevents DMBA-induced squamous cell cancer

V. Lim, S. Korourian, V. K. Todorova, Y. Kaufmann, Vicki Klimberg

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

The etiology of oral squamous cell carcinoma has been linked to environmental carcinogens, such as activated aromatic heterocyclic radicals and epoxides. Our previous work on implantable and 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer showed that oral glutamine (GLN) inhibited tumor growth possibly through stimulation of host - and selective inhibition of tumor glutathione (GSH). This finding was associated with up-regulation of NK cell activity, decreased IGF-1 and TGF-β in the circulation and downregulation of PI-3K/Akt antiapoptotic signaling in tumors. The present study was designed to investigate the effect of topically applied GLN on DMBA-induced hamster buccal pouch squamous cell carcinoma. Histopathological alterations in buccal pouches were studied by light microscopy. GLN and GSH levels in blood and buccal mucosa were determined using specific enzyme assays. The protein expression of bax, bcl-2 and PARP was determined by western blotting. H-ras and p53 genes were examined for presence of mutations using direct DNA sequencing. Fourteen weeks after DMBA application none of the GLN-supplemented animals developed tumors, while all of the control animals had well developed squamous cell carcinomas. The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and GSH, elevated buccal mucosa GSH as well as induction of bax and PARP, and inhibition of bcl-2. H-ras and p53 were wild type. The results from this study in combination with our previous data suggest that the chemopreventive effects of GLN are exerted by enhancing the antioxidant status of the body and activation of apoptosis.

Original languageEnglish (US)
Pages (from-to)148-155
Number of pages8
JournalOral Oncology
Volume45
Issue number2
DOIs
StatePublished - Feb 2009
Externally publishedYes

Fingerprint

Squamous Cell Neoplasms
9,10-Dimethyl-1,2-benzanthracene
Glutamine
Squamous Cell Carcinoma
Cheek
Mouth Mucosa
Neoplasms
Environmental Carcinogens
bcl-2-Associated X Protein
ras Genes
Mouth Neoplasms
Epoxy Compounds
p53 Genes
Enzyme Assays
Phosphatidylinositol 3-Kinases
Insulin-Like Growth Factor I
DNA Sequence Analysis
Natural Killer Cells
Cricetinae
Glutathione

Keywords

  • DMBA
  • Glutamine
  • Glutathione
  • Oral squamous cell cancer

ASJC Scopus subject areas

  • Oral Surgery
  • Oncology
  • Cancer Research

Cite this

Glutamine prevents DMBA-induced squamous cell cancer. / Lim, V.; Korourian, S.; Todorova, V. K.; Kaufmann, Y.; Klimberg, Vicki.

In: Oral Oncology, Vol. 45, No. 2, 02.2009, p. 148-155.

Research output: Contribution to journalArticle

Lim, V, Korourian, S, Todorova, VK, Kaufmann, Y & Klimberg, V 2009, 'Glutamine prevents DMBA-induced squamous cell cancer', Oral Oncology, vol. 45, no. 2, pp. 148-155. https://doi.org/10.1016/j.oraloncology.2008.04.008
Lim, V. ; Korourian, S. ; Todorova, V. K. ; Kaufmann, Y. ; Klimberg, Vicki. / Glutamine prevents DMBA-induced squamous cell cancer. In: Oral Oncology. 2009 ; Vol. 45, No. 2. pp. 148-155.
@article{9cf59609d58144d2baf8325194e552da,
title = "Glutamine prevents DMBA-induced squamous cell cancer",
abstract = "The etiology of oral squamous cell carcinoma has been linked to environmental carcinogens, such as activated aromatic heterocyclic radicals and epoxides. Our previous work on implantable and 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer showed that oral glutamine (GLN) inhibited tumor growth possibly through stimulation of host - and selective inhibition of tumor glutathione (GSH). This finding was associated with up-regulation of NK cell activity, decreased IGF-1 and TGF-β in the circulation and downregulation of PI-3K/Akt antiapoptotic signaling in tumors. The present study was designed to investigate the effect of topically applied GLN on DMBA-induced hamster buccal pouch squamous cell carcinoma. Histopathological alterations in buccal pouches were studied by light microscopy. GLN and GSH levels in blood and buccal mucosa were determined using specific enzyme assays. The protein expression of bax, bcl-2 and PARP was determined by western blotting. H-ras and p53 genes were examined for presence of mutations using direct DNA sequencing. Fourteen weeks after DMBA application none of the GLN-supplemented animals developed tumors, while all of the control animals had well developed squamous cell carcinomas. The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and GSH, elevated buccal mucosa GSH as well as induction of bax and PARP, and inhibition of bcl-2. H-ras and p53 were wild type. The results from this study in combination with our previous data suggest that the chemopreventive effects of GLN are exerted by enhancing the antioxidant status of the body and activation of apoptosis.",
keywords = "DMBA, Glutamine, Glutathione, Oral squamous cell cancer",
author = "V. Lim and S. Korourian and Todorova, {V. K.} and Y. Kaufmann and Vicki Klimberg",
year = "2009",
month = "2",
doi = "10.1016/j.oraloncology.2008.04.008",
language = "English (US)",
volume = "45",
pages = "148--155",
journal = "Oral Oncology",
issn = "1368-8375",
publisher = "Elsevier Limited",
number = "2",

}

TY - JOUR

T1 - Glutamine prevents DMBA-induced squamous cell cancer

AU - Lim, V.

AU - Korourian, S.

AU - Todorova, V. K.

AU - Kaufmann, Y.

AU - Klimberg, Vicki

PY - 2009/2

Y1 - 2009/2

N2 - The etiology of oral squamous cell carcinoma has been linked to environmental carcinogens, such as activated aromatic heterocyclic radicals and epoxides. Our previous work on implantable and 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer showed that oral glutamine (GLN) inhibited tumor growth possibly through stimulation of host - and selective inhibition of tumor glutathione (GSH). This finding was associated with up-regulation of NK cell activity, decreased IGF-1 and TGF-β in the circulation and downregulation of PI-3K/Akt antiapoptotic signaling in tumors. The present study was designed to investigate the effect of topically applied GLN on DMBA-induced hamster buccal pouch squamous cell carcinoma. Histopathological alterations in buccal pouches were studied by light microscopy. GLN and GSH levels in blood and buccal mucosa were determined using specific enzyme assays. The protein expression of bax, bcl-2 and PARP was determined by western blotting. H-ras and p53 genes were examined for presence of mutations using direct DNA sequencing. Fourteen weeks after DMBA application none of the GLN-supplemented animals developed tumors, while all of the control animals had well developed squamous cell carcinomas. The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and GSH, elevated buccal mucosa GSH as well as induction of bax and PARP, and inhibition of bcl-2. H-ras and p53 were wild type. The results from this study in combination with our previous data suggest that the chemopreventive effects of GLN are exerted by enhancing the antioxidant status of the body and activation of apoptosis.

AB - The etiology of oral squamous cell carcinoma has been linked to environmental carcinogens, such as activated aromatic heterocyclic radicals and epoxides. Our previous work on implantable and 7,12-dimethylbenz[a]anthracene (DMBA)-induced breast cancer showed that oral glutamine (GLN) inhibited tumor growth possibly through stimulation of host - and selective inhibition of tumor glutathione (GSH). This finding was associated with up-regulation of NK cell activity, decreased IGF-1 and TGF-β in the circulation and downregulation of PI-3K/Akt antiapoptotic signaling in tumors. The present study was designed to investigate the effect of topically applied GLN on DMBA-induced hamster buccal pouch squamous cell carcinoma. Histopathological alterations in buccal pouches were studied by light microscopy. GLN and GSH levels in blood and buccal mucosa were determined using specific enzyme assays. The protein expression of bax, bcl-2 and PARP was determined by western blotting. H-ras and p53 genes were examined for presence of mutations using direct DNA sequencing. Fourteen weeks after DMBA application none of the GLN-supplemented animals developed tumors, while all of the control animals had well developed squamous cell carcinomas. The inhibition of DMBA-carcinogenesis by GLN application was associated with increased arterial GLN and GSH, elevated buccal mucosa GSH as well as induction of bax and PARP, and inhibition of bcl-2. H-ras and p53 were wild type. The results from this study in combination with our previous data suggest that the chemopreventive effects of GLN are exerted by enhancing the antioxidant status of the body and activation of apoptosis.

KW - DMBA

KW - Glutamine

KW - Glutathione

KW - Oral squamous cell cancer

UR - http://www.scopus.com/inward/record.url?scp=58549097263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58549097263&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2008.04.008

DO - 10.1016/j.oraloncology.2008.04.008

M3 - Article

C2 - 18635390

AN - SCOPUS:58549097263

VL - 45

SP - 148

EP - 155

JO - Oral Oncology

JF - Oral Oncology

SN - 1368-8375

IS - 2

ER -